Vibrio vulnificus. Vibrio vulnificus V. vulnificus. pectinata japonica)

Similar documents
Routine internal quality control as recommended by EUCAST Version 3.1, valid from

EUCAST recommended strains for internal quality control

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Methicillin-resistant coagulase-negative staphylococci Methicillin-resistant. spa Staphylococcus aureus

SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* ...

European Committee on Antimicrobial Susceptibility Testing

2015 Antibiotic Susceptibility Report

AMR Industry Alliance Antibiotic Discharge Targets

2016 Antibiotic Susceptibility Report

January 2014 Vol. 34 No. 1

Antimicrobial Susceptibility Patterns

levofloxacin (LVFX) LVFX LVFX LVFX Key words: Levofloxacin Escherichia coli LVFX levofloxacin (LVFX) Vol. 18 No

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

What s new in EUCAST methods?

European Committee on Antimicrobial Susceptibility Testing

56 Clinical and Laboratory Standards Institute. All rights reserved.

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی

CONTAGIOUS COMMENTS Department of Epidemiology

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER

Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV

Antimicrobial Susceptibility Testing: The Basics

Principles of Antimicrobial Therapy

Color: Black/Tan NO GROWTH ON SOLID MEDIA IN 48 HRS. NO GROWTH ON SOLID MEDIA IN 24 HRS.

January 2014 Vol. 34 No. 1

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Antimicrobial Susceptibility Testing: Advanced Course

Interactive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

- the details, where possible, of the antibiotic products these companies supply or have supplied.

CONTAGIOUS COMMENTS Department of Epidemiology

CONTAGIOUS COMMENTS Department of Epidemiology

REVOLUTIONARY. MMinimum. BBiofilm EEradication Concentration. inimizing WE HAVE FOUND THE ANSWER.

Chapter Anaerobic infections (individual fields): intraperitoneal infections (acute peritonitis, hepatobiliary infections, etc.

OPAT discharge navigator and laboratory monitoring Select OPAT button for ALL patients that discharge on intravenous antimicrobials

Cost high. acceptable. worst. best. acceptable. Cost low

Recommendations to take it forward!

Antimicrobial Chemotherapy

Case 2 Synergy satellite event: Good morning pharmacists! Case studies on antimicrobial resistance

MicroScan Microbiology Systems MORE CHOICES MORE ANSWERS. MicroScan GRAM NEGATIVE AND GRAM POSITIVE PANELS

Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how?

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018

Approach to pediatric Antibiotics

QUICK REFERENCE. Pseudomonas aeruginosa. (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.)

GENERAL NOTES: 2016 site of infection type of organism location of the patient

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Antimicrobial Pharmacodynamics

Drug resistance analysis of bacterial strains isolated from burn patients

Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India

Antibiotic Updates: Part II

Outline. Antimicrobial resistance. Antimicrobial resistance in gram negative bacilli. % susceptibility 7/11/2010

Cell Wall Weakeners. Antimicrobials: Drugs that Weaken the Cell Wall. Bacterial Cell Wall. Bacterial Resistance to PCNs. PCN Classification

Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes

1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient

Concise Antibiogram Toolkit Background

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines

Performance Information. Vet use only

PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS

This document is protected by international copyright laws.

Antimicrobial susceptibility

Bacteriological Study of Catheter Associated Urinary Tract Infection in a Tertiary Care Hospital

Antibiotic Susceptibility of Common Bacterial Pathogens in Canine Urinary Tract Infections

Introduction to Pharmacokinetics and Pharmacodynamics

microbiology testing services

EUCAST-and CLSI potency NEO-SENSITABS

RCH antibiotic susceptibility data

Measure Information Form

3 party manufacturing PRODUCT LIST. Category : ANTI BIOTIC

* gender factor (male=1, female=0.85)

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015

Is Clostridium difficile infection influenced by antimicrobial use density in wards?

Necrotizing Soft Tissue Infections: Emerging Bacterial Resistance

General Approach to Infectious Diseases

Should we test Clostridium difficile for antimicrobial resistance? by author

Intrinsic, implied and default resistance

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS

BSAC standardized disc susceptibility testing method (version 8)

Understanding the Hospital Antibiogram

The β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

I am writing in response to your request for information made under the Freedom of Information Act 2000 in relation to Antibiotics.

Breaking the Ring. β-lactamases and the Great Arms Race. Bryce M Kayhart, PharmD, BCPS PGY2 Pharmacotherapy Resident Mayo Clinic - Rochester

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance

Introduction. Antimicrobial Usage ESPAUR 2014 Previous data validation Quality Premiums Draft tool CDDFT Experience.

4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES

Canadian Nosocomial Infection Surveillance Program 2018 SURVEILLANCE FOR HEALTHCARE ACQUIRED CEREBROSPINAL FLUID SHUNT ASSOCIATED INFECTIONS

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

Antimicrobial Therapy

Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity.

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

Anti-infection Agents

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

Transcription:

2006 1 Vibrio vulnificus 1 1) 1) 1) 2) 1) 1) 2) 17 5 16 17 11 17 Vibrio vulnificus V. vulnificus 7 9 11 79 2004 11 14 (Atrina pectinata japonica) 3 11 17 16 A B 20 11 17 V. vulnificus 7 9 11 Key words: Vibrio vulnificus, V. vulnificus infection in winter season, import of fresh fish and shellfishes Vibrio vulnificus 1) 3) 70 38.5 3 54.7 3 4) 20 7 9 4) 6), 7) 20 5) 3 11 1 12 2 4) 11 ( 830 0011) 67 TEL: 0942 35 3311 5445 FAX: 0942 31 7760 I. 79 1991 C 2004 11 14 Vol. 16 No. 1 2006. 1

2 (Atrina pectinata japonica) (Fig. 1) 3 11 17 16 Japan Coma Scale 1 71/45 mmhg A B B 33.2 68/ 87/30 B CK sulbactam / cefoperazone (SBT/CPZ) 1 g 20 (Table 1) CK CRP Japan Coma Scale 1, Glasgow Coma Scale 13 33.6 20/ 76/ 74/ mmhg (Fig. 2) necrosis panipenem/betamipron (PAPM/BP) 2.0 g/ clindamycin (CLDM) 2400 mg/ 11 18 Table 1. Laboratory findings on admission. Results Reference limits Blood chemistry AST (GOT) 725 U/l 13 33 ALT (GPT) 215 U/l 8 42 LD 584 U/l 119 229 ALP 232 U/l 115 359 T.B 2.44 mg/100 ml 1.5 D.B 1.41 mg/100 ml 0.6 TP 4.4 g/100 ml 6.7 8.3 ALB 2.06 g/100 ml 4.0 5.0 UN 45.4 mg/100 ml 8 22 Crea 1.68 mg/100 ml 0.6 1.1 UA 8.91 mg/100 ml 3.6 8.0 Ca 7.17 mg/100 ml 8.7 10.3 CK 19910 U/l 62 287 CKMB 381 U/l 6 28 Amylase 54 U/l 50 159 Serological tests CRP 6.23 mg/100 ml 0.4 HBsAg below sensitivity CBC WBC 17 10 2 /ml 40 90 RBC 374 10 4 /ml 430 570 Hb 13.3 g/100 ml 14 18 Ht 37.3 40 52 Plt 2.8 10 4 /ml 13 36 Coagulation PT 40 60 130 FDP 6.4 mg/ml 2.5 Fib 212 g/100 ml 200 400 AT- 11 84 117 PLG 19 96 117 II. 1. 11 17 BacT / ALERT 3D system SA SN 11 18 2 Vol. 16 No. 1 2006.

Vibrio vulnificus 3 2. 1) G 2) 5 TSA 5 SB DHL HK (RS) Vibrio TCBS TGC BacT / ALERT 3D 3) TCBS Vibrio Micro Scan Walk Away SI 96 (DADE BEHRING) 8) (DADE BEHRING) Micro Scan Neg BP Combo 3J (DADE BEHRING) 0.85 MacFarland 0.5 50 ml 0, 0.5, 1, 3, 8, 10 NaCl O/129 10 mg 150 mg 9) Staphylococcus Micro Scan Pos BP Combo 41J (DADE BEHRING) 4) Micro Scan Walk Away SI 96 8) Micro Scan Pos BP Combo 41J 3. 1) 2) TSA 5 SB HK TCBS 4mm S (Fig. 3) DHL HK TCBS 4 TGC TGC TSA 5 SB TSA 5 SB 5 3) Micro Scan Walk Away SI 96 V. vulnificus 40050017 0.5, 1 3 NaCl O/129 10 mg 150 mg V. vulnificus Staphylococcus epidermidis 4) V. vulnificus minocyclin 2), 3) V. vulnificus Vol. 16 No. 1 2006. 3

4 Fig. 1. Atrina pectinata japonica Fig. 4. Pathological analysis of the right-leg muscles obtained from the autopsied patient. Infiltration by inflammatory cells mainly neutrophils, was observed at perivascular and intermuscular areas. Muscle tissues were partially necrotized. (HE stain 200) Fig. 2. Red-purple colored change of the lower extremities, and enlarged right lower extremity. Fig. 3. Growth of V. vulnificus on Trypticase Soy Agar with 5 Sheep Blood (left) and TCBS Agar (right). Fig. 5. Microbiological analysis of the right-leg muscles obtained from the autopsied patient Gram negative cocci, and rods were mainly observed. (Gram stain 1000) 4 Vol. 16 No. 1 2006.

Vibrio vulnificus 5 Table 2. Drug susceptibility test of Vibrio vulnificus and Staphylococcus epidermidis. MIC (mg/ml Vibrio vulnificus Staphylococcus epidermidis Ampicillin 8 Penicillin G 8 Piperacillin 16 Oxacillin 2 Amoxicillin/clavulanic acid 8 Ampicillin 8 Cefoprazon/sulbactam 16 Piperacillin 64 Cefazolin 8 Ampicillin/sulbactam 8 Cefaclor 8 Amoxicillin/clavulanic acid 4 Cefotiam 16 Cefoprazon/sulbactam 16 Cefoperazone 16 Cefazolin 8 Cefotaxime 8 Cefotiam 8 Cefpodoxime 2 Cefotaxime 4 Ceftazidime 8 Cefpodoxime 2 Cefozopram 16 Cefdinir 8 Cefepime 8 Cefozopram 16 Cefpirome 8 Cefepime 8 Cefsulodin 16 Cefpirome 8 Cefmetazole 16 Flomoxef 4 Latamoxef 8 Imipenem 8 Flomoxef 8 Meropenem 2 Aztreonam 16 Norfloxacin 4 Imipenem 4 Gentamicin 8 Meropenem 4 Arbekacin 4 Levofloxacin 2 Minocyclin 4 Ciprofloxacin 1 Clindamycin 2 Gentamicin 4 Erythromycin 4 Tobramycin 8 Clarithromycin 4 Amikacin 32 Vancomycin 2 Minocyclin 4 Teicoplanin 8 Sulfomethoxazole/trimethoprim 0.5 Sulfomethoxazole/trimethoprim 2 Fosfomycin 4 Fosfomycin 4 S. epidermidis oxacillin arbekacin, vancomycin, teicoplanin (Table 2) III. (Fig. 4) (Fig. 5) V. vulnificus V. vulnificus contamination IV. V. vulnificus 4 V. vulnificus 72 100 1), 10) 3 Vol. 16 No. 1 2006. 5

6 V. vulnificus V. vulnificus 1), 4) PAPM/BP PBP-1a 1b 2 4), 11) S. epidermidis MRS Bacterial translocation V. vulnificus 2001 1 12 V. vulnificus 20 550 122 (22.2 ) V. vulnificus 5 10 25.6 (78/305) 11 4 18.0 (44/245) 1 2 12 1 (8.3 ) 5) 12) 2004 2005 13) V. vulnificus 5) 17 17590505 1) 2001 Vibrio vulnificus 50: 526 531 2) 1999 Vibrio vulnificus 54: 586 593 3) 1998 INFECTION CONTROL 7: 282 288 4) 1999 Vibrio vulnificus 109: 875 884 5) 2004 Vibrio vulnificus 7: 580 586 6) 2002 Vibrio vulnificus 1 76: 63 66 7) 2003 Vibrio vulnificus 1 77: 167 173. 8) 2004 Vibrio 53: 933 939 9) 2001 Modern Media 47: 272 282 10) Klontz, K. C., S. Lieb, M. Chreiber, et al 1998 Syndrome of Vibrio vulnificus infections Clini- 6 Vol. 16 No. 1 2006.

Vibrio vulnificus 7 cal and epidemiological features in Florida cases 1981 1987 Ann Intern Med 109: 318 323 11) Jackson, J. J., H. Kropp. 1992 b-lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP)2-specific imipenem and PBP3-specific ceftazidime J Infect Dis 165: 1033 1041 12) 2003 24: 317 318. 13) 2002 84: 554 555 A Case of Vibrio vulnificus Infection Occurring in the Winter Season Rie Horita 1),Kouji Hashimoto 1),Kazunori Nakata 1),Kanta Kikuma 2),Kimitaka Sagawa, MD 1) 1) Department of Laboratory Medicine, Kurume University Hospital 2) Emergency and Critical Care Medical Center, Kurume University Hospital We report a rare case of Vibrio vulnificus infection that occurred in the winter season. A 79 year-old single male with liver cirrhosis ate raw Atrina pectinata shellfish in his house on November 14, 2004. On November 17 a neighbor discovered him lying in bed, unable to walk due to severe leg pain that had started soon after he had eaten the raw shellfish meat. He was admitted to the Emergency and Critical Care Medical Center of Kurume University Hospital. Physical examination of the patient revealed Japan Coma Scale 1, respiratory rate 20/min, body temperature 33.6, pulse rate 76/min, blood pressure 74/ mmhg, red-purple colored change of the lower extremities, and enlarged right lower extremity. The right lower extremity was sectioned in order to relieve the higher pressure. The sectioned leg exhibit a bad smell, necrotized muscles, and exudates. Although intensive therapies were applied, the patient was expired on November 18. Pathological analysis of the right-leg muscles obtained from the autopsied patient showed typical features of V. vulnificus infection. Vol. 16 No. 1 2006. 7